USE OF CHIMERIC ANTI-CD20 ANTIBODY AS IN VITRO OR IN VIVO PURGING AGENT IN PATIENTS RECEIVING BMT OR PBSC TRANSPLANT

• 收藏
• 分享

专利权人:

Antonio J. GRILLO-LOPEZ

发明人:

Antonio J. GRILLO-LOPEZ,John LEONARD

申请号：

US13914421

公开号：

US20130273041A1

申请日:

2013.06.10

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The use of anti-CD20 antibodies as in vivo purging agents for patients receiving bone marrow or peripheral blood stem cell transplant during treatment of B-cell-related diseases, e.g., B-cell lymphomas or leukemias, is disclosed. Such purging may enhance engraftment and/or prevent disease relapse in such patients.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/